These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 24655115)

  • 21. Intranasal delivery of tapentadol hydrochloride-loaded chitosan nanoparticles: formulation, characterisation and its in vivo evaluation.
    Javia A; Thakkar H
    J Microencapsul; 2017 Nov; 34(7):644-658. PubMed ID: 28862072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nose-to-brain delivery: evaluation of polymeric nanoparticles on olfactory ensheathing cells uptake.
    Musumeci T; Pellitteri R; Spatuzza M; Puglisi G
    J Pharm Sci; 2014 Feb; 103(2):628-35. PubMed ID: 24395679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chitosan coated human serum albumin nanoparticles: A promising strategy for nose-to-brain drug delivery.
    Piazzini V; Landucci E; D'Ambrosio M; Tiozzo Fasiolo L; Cinci L; Colombo G; Pellegrini-Giampietro DE; Bilia AR; Luceri C; Bergonzi MC
    Int J Biol Macromol; 2019 May; 129():267-280. PubMed ID: 30726749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lactoferrin-modified rotigotine nanoparticles for enhanced nose-to-brain delivery: LESA-MS/MS-based drug biodistribution, pharmacodynamics, and neuroprotective effects.
    Yan X; Xu L; Bi C; Duan D; Chu L; Yu X; Wu Z; Wang A; Sun K
    Int J Nanomedicine; 2018; 13():273-281. PubMed ID: 29391788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization.
    Shahnaz G; Vetter A; Barthelmes J; Rahmat D; Laffleur F; Iqbal J; Perera G; Schlocker W; Dünnhaput S; Augustijns P; Bernkop-Schnürch A
    Int J Pharm; 2012 May; 428(1-2):164-70. PubMed ID: 22421322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formulation, development and optimization of raloxifene-loaded chitosan nanoparticles for treatment of osteoporosis.
    Saini D; Fazil M; Ali MM; Baboota S; Ali J
    Drug Deliv; 2015; 22(6):823-36. PubMed ID: 24725026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain pharmacokinetics of neurotoxin-loaded PLA nanoparticles modified with chitosan after intranasal administration in awake rats.
    Zhang X; Liu L; Chai G; Zhang X; Li F
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1618-24. PubMed ID: 24087853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and evaluation of thermo-responsive nasal in situ gelling system dispersed with piribedil loaded lecithin-chitosan hybrid nanoparticles for improved brain availability.
    Uppuluri CT; Ravi PR; Dalvi AV
    Neuropharmacology; 2021 Dec; 201():108832. PubMed ID: 34627852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nose to brain delivery of rotigotine loaded chitosan nanoparticles in human SH-SY5Y neuroblastoma cells and animal model of Parkinson's disease.
    Bhattamisra SK; Shak AT; Xi LW; Safian NH; Choudhury H; Lim WM; Shahzad N; Alhakamy NA; Anwer MK; Radhakrishnan AK; Md S
    Int J Pharm; 2020 Apr; 579():119148. PubMed ID: 32084576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Formulation and characterization of intranasal mucoadhesive nanoparticulates and thermo-reversible gel of levodopa for brain delivery.
    Sharma S; Lohan S; Murthy RS
    Drug Dev Ind Pharm; 2014 Jul; 40(7):869-78. PubMed ID: 23600649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of two efflux proteins, ABCB1 and ABCG2 in blood-brain barrier transport of bromocriptine in a murine model of MPTP-induced dopaminergic degeneration.
    Vautier S; Milane A; Fernandez C; Chacun H; Lacomblez L; Farinotti R
    J Pharm Pharm Sci; 2009; 12(2):199-208. PubMed ID: 19732497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Venlafaxine loaded chitosan NPs for brain targeting: pharmacokinetic and pharmacodynamic evaluation.
    Haque S; Md S; Fazil M; Kumar M; Sahni JK; Ali J; Baboota S
    Carbohydr Polym; 2012 Jun; 89(1):72-9. PubMed ID: 24750606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intranasal delivery of dopamine to the striatum using glycol chitosan/sulfobutylether-β-cyclodextrin based nanoparticles.
    Di Gioia S; Trapani A; Mandracchia D; De Giglio E; Cometa S; Mangini V; Arnesano F; Belgiovine G; Castellani S; Pace L; Lavecchia MA; Trapani G; Conese M; Puglisi G; Cassano T
    Eur J Pharm Biopharm; 2015 Aug; 94():180-93. PubMed ID: 26032293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. inPentasomes: An innovative nose-to-brain pentamidine delivery blunts MPTP parkinsonism in mice.
    Rinaldi F; Seguella L; Gigli S; Hanieh PN; Del Favero E; Cantù L; Pesce M; Sarnelli G; Marianecci C; Esposito G; Carafa M
    J Control Release; 2019 Jan; 294():17-26. PubMed ID: 30529726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanotechnology-mediated nose to brain drug delivery for Parkinson's disease: a mini review.
    Kulkarni AD; Vanjari YH; Sancheti KH; Belgamwar VS; Surana SJ; Pardeshi CV
    J Drug Target; 2015; 23(9):775-88. PubMed ID: 25758751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chitosan nanoparticles for intranasal delivery of olmesartan medoxomil: Pharmacokinetic and pharmacodynamic perspectives.
    Hassan RH; Gad HA; El-Din SB; Shaker DS; Ishak RAH
    Int J Pharm; 2022 Nov; 628():122278. PubMed ID: 36243325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanoparticle transport across in vitro olfactory cell monolayers.
    Gartziandia O; Egusquiaguirre SP; Bianco J; Pedraz JL; Igartua M; Hernandez RM; Préat V; Beloqui A
    Int J Pharm; 2016 Feb; 499(1-2):81-89. PubMed ID: 26721725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The nasal delivery of nanoencapsulated statins - an approach for brain delivery.
    Clementino A; Batger M; Garrastazu G; Pozzoli M; Del Favero E; Rondelli V; Gutfilen B; Barboza T; Sukkar MB; Souza SA; Cantù L; Sonvico F
    Int J Nanomedicine; 2016; 11():6575-6590. PubMed ID: 27994459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formulation and In-vivo Pharmacokinetic Consideration of Intranasal Microemulsion and Mucoadhesive Microemulsion of Rivastigmine for Brain Targeting.
    Shah B; Khunt D; Misra M; Padh H
    Pharm Res; 2018 Jan; 35(1):8. PubMed ID: 29294189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-invasive intranasal delivery of quetiapine fumarate loaded microemulsion for brain targeting: Formulation, physicochemical and pharmacokinetic consideration.
    Shah B; Khunt D; Misra M; Padh H
    Eur J Pharm Sci; 2016 Aug; 91():196-207. PubMed ID: 27174656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.